AAV2/5-hRKp.RPGR

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
90	網膜色素変性症	2

90. 網膜色素変性症

臨床試験数 : 147 / 薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-000425-31-GB (EUCTR)	30/08/2018	14/06/2018	Long term follow-up study of gene therapy trial for X-linked Retinitis Pigmentosa	Long term follow-up study of participants following an open label, multicentre, Phase I/II dose esca ...	X-Linked Retinitis Pigmentosa caused by mutations in the RPGR gene MedDRA version: 20.0;Level: PT;Cl ...	Product Name: AAV2/5-hRKp.RPGR	MeiraGTx UK II Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	36	Phase 1;Phase 2	United States;United Kingdom
2	EUCTR2016-003967-21-GB (EUCTR)	09/06/2017	14/09/2017	Gene Therapy Trial for People with Retinitis Pigmentosa (progressive reduction in vision) due to a g ...	An open label, multi-centre, Phase I/II dose escalation trial of a recombinant adeno-associated viru ...	X-Linked Retinitis Pigmentosa caused by mutations in the RPGR gene MedDRA version: 20.0;Level: PT;Cl ...	Product Name: AAV2/5-hRKp.RPGR INN or Proposed INN: AAV2/5-hRKp.RPGR	MeiraGTx UK II Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes	71	Phase 1;Phase 2	United States;United Kingdom

First Previous1Next Last